Kosé is developing personalized skin care using consumers’ own iPS cells via Global Cosmetic Industry
11 July 2024
Kosé is partnering with I Peace, Inc. and Reju, Inc. to develop personalized beauty products comprising iPSF (an induced pluripotent stem [iPS] cell extract) derived from customers’ own blood-drawn cells.
This process will reportedly optimize dosages and textures for each consumer; finished products will reportedly be “provided through medical institutions under medical supervision,” per Kosé.
By the end of 2024, iPSF-based formulations will commence demonstrating testing in Japan.